|
Predictors of cardiovascular events |
|||
| Cardiovascular events (+) (n = 33) |
Cardiovascular events (-) (n = 53) |
p-value |
|
|
|
|||
| Age, years |
56 ± 13 |
58 ± 12 |
0.18 |
| Gender, male |
28 (85%) |
45 (85%) |
0.99 |
| History of hypertension |
22 (67%) |
32 (60%) |
0.56 |
| History of hyperlipidemia |
22 (67%) |
37 (70%) |
0.76 |
| History of diabetes |
11 (33%) |
13 (25%) |
0.38 |
| Beta Blocker Use |
25 (81%) |
37 (77%) |
0.10 |
| Ace-I or ARB Use |
18 (58%) |
27 (56%) |
0.25 |
| History of smoking |
13 (39%) |
13 (25%) |
0.14 |
| Coronary anatomy, n (%) |
|||
| 1 vessel disease |
3 (9%) |
10 (19%) |
0.22 |
| 2 vessels disease |
10 (30%) |
14 (26%) |
0.70 |
| 3 vessels disease |
20 (61%) |
29 (55%) |
0.59 |
|
Values are expressed as a mean ± SD. Ace-I = Angiotensin Converting Enzyme – Inhibitor, ARB = Angiotensin Receptor Blocker | |||
Yokota et al. Journal of Cardiovascular Magnetic Resonance 2008 10:17 doi:10.1186/1532-429X-10-17 |
|||